Back

Outcomes in functionally guided DCB versus stent PCI: a propensity-matched analysis

1 September 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Choosing the optimal devices in percutaneous coronary intervention Devices ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Antonio Maria Leone

Catholic University of the Sacred Heart, Rome (Italy)

7 More presentations in this session

Presentation thumbnail
Long-term outcomes of drug coated balloons versus drug eluting stents in patients with small vessel coronary artery disease
Assistant Professor M. Arab (Zagazig, EG)
Abstract Slides Video
Presentation thumbnail
Sex-specific outcomes following percutaneous coronary interventions with drug-coated balloons
Miss L. Stutz (Luzern, CH)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of stent-less percutaneous coronary intervention with intravascular lithotripsy and drug-coated balloon for severely calcified de novo coronary lesions.
Doctor T. Misawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease
Doctor H. Rai (Dublin 7, IE)
Abstract Slides Video
Presentation thumbnail
Comparison of two different paclitaxel-coated balloons in small native coronary vessel disease
Doctor J. Lee (Incheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Choosing the optimal devices in percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

1 September 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Drug coated balloons-based approach versus conventional percutaneous coronary intervention with drug eluting stents for left anterior descending revascularization
thumbnail
Congress Presentation
Outcomes of drug eluting stents vs. drug eluting balloons. A single center experience.
thumbnail
Congress Session
Long-term outcomes and innovations in revascularisation strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources